已核实 DOI PubMed 相关产品: 0

A novel cascade enzyme/fenton reaction approach for enhanced chemodynamic and starvation therapy

Journal 2026 · IF 9.6 · 发表于 2026 年 6 月 6 日
作者: Zhaomin Tang,Kanglin Chen,Qiuye Jin,Yudong Wang,Yaning Ou,Wenxin Liao,Junbo Song,Yuhua Xiang,Yutong Wu,Donglian Liu
阅读全文 在 PubMed 查看

摘要

Atomically dispersed Cu N 4 sites maximize catalytic efficiency for Fenton-like ·OH generation. • Glucose oxidase (GOx) integration simultaneously fuels ROS production, acidifies tumor microenvironment(TME), and starves tumor cells via ATP depletion. • Hyaluronic acid (HA)-mediated CD44 targeting enables tumor-specific activation with 83.6% inhibition. This study has constructed a hyaluronic acid (HA) modified hollow mesoporous copper single-atom nanozyme HA@Cu-SAC@GOx for synergistically enhancing trimodal antitumor therapy, encompassing chemodynamic therapy, starvation therapy, and pyroptosis induction. The system employs hollow mesoporous carbon spheres as a carrier, with atomically dispersed copper single atoms through Cu N 4 coordination structure. Glucose oxidase (GOx) is encapsulated within the cavity, while the surface is modified with hyaluronic acid via electrostatic adsorption, conferring targeting capability toward CD44-overexpressing tumor cells. Upon reaching the tumor microenvironment, HA is degraded by hyaluronidase (HAase), triggering the release of GOx. The released GOx catalyzes glucose oxidation to generate hydrogen peroxide (H 2 O 2 ) while depleting adenosine triphosphate (ATP), thereby achieving starvation therapy. Simultaneously, the in situ generated H 2 O 2 is efficiently converted into highly toxic hydroxyl radicals (‧OH) via Cu-SAC-mediated Fenton-like reactions under weakly acidic conditions, significantly enhancing chemodynamic therapeutic efficacy. This process also consumes substantial glutathione (GSH), disrupts the intracellular redox homeostasis, induces mitochondrial damage, and activates caspase-1, subsequently triggering GSDME-mediated pyroptosis. These interconnected mechanisms collectively generate a synergistic antitumor effect. In a 4T1 tumor-bearing mouse model, a single intravenous injection achieved an 83.6% tumor growth inhibition rate after 14 days and a 100% survival rate at 40 days, with no significant systemic toxicity observed. This study validates the potential of HA@Cu-SAC@GOx as an efficient and low-toxicity combinatorial therapeutic strategy, providing a crucial theoretical and experimental foundation for the clinical translation of single-atom nanozymes. A hyaluronic acid-modified hollow mesoporous copper single-atom nanozyme (HA@Cu-SAC@GOx) was engineered for synergistic trimodal antitumor therapy. The nanoplatform features atomically dispersed Cu N 4 active sites within hollow carbon spheres, with glucose oxidase (GOx) encapsulated in the cavity and hyaluronic acid (HA) surface modification. Upon CD44-mediated tumor targeting and hyaluronidase-triggered GOx release, the cascade reaction generates H 2 O 2 from glucose oxidation, which is subsequently converted to highly toxic hydroxyl radicals (‧OH) via Cu-SAC-catalyzed Fenton-like reactions under acidic tumor microenvironment conditions. Concurrent GSH depletion disrupts redox homeostasis, induces mitochondrial damage, and activates caspase-1/GSDME-mediated pyroptosis. This integrated chemodynamic/starvation/pyroptosis therapy achieves 83.6% tumor growth inhibition with 100% survival rate and excellent biocompatibility, offering a potent single-atom nanozyme-based therapeutic strategy for precision cancer treatment. Download: Download high-res image (166KB) Download: Download full-size image